Korean Gynecologic Oncology Group   Report issue

Academic/Hospital Phase 2 Phase 3
Founded: Seoul Korea, Republic of (2002)

Organization Overview

First Clinical Trial
2004
NCT00340184
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

KGOG: Korean Gynaelogical Onology Group, Korea | Korean Gynecologic Oncologic Group | Korean Gynecologic Oncology Group

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Ovarian Epithelial (Phase 3)

Endometrial Neoplasms (Phase 2)

Fallopian Tube Neoplasms (Phase 2)

Ovarian Neoplasms (Phase 3)

Peritoneal Neoplasms (Phase 2)

Uterine Cervical Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 8
  • # of Trial APIs: 10